Home Other Building Blocks 2651-43-6
2651-43-6,MFCD04039564
Catalog No.:AA002TFX

2651-43-6 | 3-Hydroxypropanamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
96%
in stock  
$103.00   $73.00
- +
1g
97%
in stock  
$164.00   $115.00
- +
5g
96%
in stock  
$735.00   $514.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA002TFX
Chemical Name:
3-Hydroxypropanamide
CAS Number:
2651-43-6
Molecular Formula:
C3H7NO2
Molecular Weight:
89.0932
MDL Number:
MFCD04039564
SMILES:
NC(=O)CCO
Properties
Computed Properties
 
Complexity:
52.8  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
6  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
2  
XLogP3:
-1.6  

Downstream Synthesis Route

[1]Battilocchio,Claudio;Hawkins,JoelM.;Ley,StevenV.[OrganicLetters,2014,vol.16,#4,p.1060-1063]

[2]Xing,Xiangyou;Xu,Chen;Chen,Bo;Li,Chengcheng;Virgil,ScottC.;Grubbs,RobertH.[JournaloftheAmericanChemicalSociety,2018,vol.140,#50,p.17782-17789]

[3]CurrentPatentAssignee:SOUTHERNUNIVERSITYOFSCIENCEANDTECHNOLOGYOFCHINA-CN110642895,2020,ALocationinpatent:Paragraph0142-0146

[4]Breuilles;Leclerc;Uguen[TetrahedronLetters,1994,vol.35,#9,p.1401-1404]

[5]CurrentPatentAssignee:PFIZERINC-US2415645,1944,A

[6]Chadha;Leidal;Plapp[JournalofMedicinalChemistry,1983,vol.26,#6,p.916-922]

[7]Breuilles;Leclerc;Uguen[TetrahedronLetters,1994,vol.35,#9,p.1401-1404]

[8]Hann,EugeniaC.;Sigmund,AmyE.;Fager,SusanK.;Cooling,FrederickB.;Gavagan,JohnE.;Ben-Bassat,Arie;Chauhan,Sarita;Payne,MarkS.;Hennessey,SusanM.;DiCosimo,Robert[AdvancedSynthesisandCatalysis,2003,vol.345,#6-7,p.775-782]

[9]Locationinpatent:experimentalpartCavarzan,Alessandra;Scarso,Alessandro;Strukul,Giorgio[GreenChemistry,2010,vol.12,#5,p.790-794]

[1]Patent:US4237067,1980,A

[1]CurrentPatentAssignee:EVONIKINDUSTRIESAG-US4237067,1980,A

[1]Patent:WO2012/66488,2012,A2.Locationinpatent:Page/Pagecolumn69

[2]Patent:US2013/231319,2013,A1.Locationinpatent:Paragraph0575

Literature

Title: Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany.

Journal: Cellular and molecular life sciences : CMLS 20120301

Title: 3α-Hydr-oxy-N-(3-hydroxy-prop-yl)-5β-cholan-24-amide.

Journal: Acta crystallographica. Section E, Structure reports online 20090301

Title: The novel phosphoramidate derivatives of NSAID 3-hydroxypropylamides: synthesis, cytostatic and antiviral activity evaluations.

Journal: European journal of medicinal chemistry 20090101

Title: Synthesis and anticonvulsant activity of a class of 2-amino 3-hydroxypropanamide and 2-aminoacetamide derivatives.

Journal: Bioorganic & medicinal chemistry 20060515

Title: Synthesis of submicrometer-sized titania spherical particles with a sol-gel method and their application to colloidal photonic crystals.

Journal: Journal of colloid and interface science 20051101

Title: Docking and 3-D QSAR studies on indolyl aryl sulfones. Binding mode exploration at the HIV-1 reverse transcriptase non-nucleoside binding site and design of highly active N-(2-hydroxyethyl)carboxamide and N-(2-hydroxyethyl)carbohydrazide derivatives.

Journal: Journal of medicinal chemistry 20050113

Title: Mechanisms of acrylamide formation: Maillard-induced transformation of asparagine.

Journal: Advances in experimental medicine and biology 20050101

Title: Bile acid amidoalcohols: simple organogelators.

Journal: Biosensors & bioelectronics 20041215

Title: In-depth mechanistic study on the formation of acrylamide and other vinylogous compounds by the maillard reaction.

Journal: Journal of agricultural and food chemistry 20040825

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:2651-43-6 Molecular Formula|2651-43-6 MDL|2651-43-6 SMILES|2651-43-6 3-Hydroxypropanamide